Illumina in EU antitrust sights over premature $8 bln Grail deal - NewsBreak

BRUSSELS, Aug 20 (Reuters) - U.S. life sciences company Illumina (ILMN.O) could face a hefty fine for jumping the gun by completing its $8 billion cash-and-stock takeover of cancer detection test maker Grail (GRAL.O) without first securing EU antitrust approval. Illumina closed the Grail takeover on Wednesday and said it...